AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Low Doses Of GM-CSF Not Enough To Stimulate Neutralizing Antibodies.(Brief Article)

Vaccine Weekly

| June 20, 2001 | COPYRIGHT 2001 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2001 JUN 20 - (NewsRx.com & NewsRx.net) --

by N.R. Saltmarsh, staff medical writer - Cancer and myeloma patients administered granulocyte-macrophage colony-stimulating factor (GM-CSF) for immune stimulation may produce GM-CSF-specific antibodies but not enough to neutralize its effects, according to a report in Clinical Immunology.

"We have assessed the immunogenicity profile of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with either colorectal carcinoma (CRC) at different stages of disease or with multiple myeloma who were given recombinant human GM-CSF (Escherichia coli-derived) combination therapy," reported G. Ullenhag and colleagues in Sweden.

The researchers administered high doses of GM-CSF (425-500 (micro)g/day for 10 days) to patients with advanced CRC, along with a colon cancer-reactive antibody. Other CRC patients and those with myeloma got low doses (75-80 (micro)g/day for four days) of GM-CSF adjuvant with appropriate tumor antigens.

Only 16% of low-dose patients developed GM-CSF-specific antibodies, compared with 55% of high-dose patients, and none developed neutralizing antibodies, said Ullenhag and coworkers.

Eighty percent of patients also developed antibodies to E. coli proteins that had contaminated the GM-CSF ("Incidence of GM-CSF antibodies in cancer patients ...

Related articles from newspapers, magazines, journals, and more
GM-CSF speeds recovery of white blood cells in bone marrow transplant patients....
Press release article from: PR Newswire May 24, 1988 700+ words
GM-CSF SPEEDS RECOVERY OF WHITE BLOOD CELLS IN BONE...macrophage colony stimulating factor (GM-CSF) demonstrated markedly earlier signs of...than transplant patients who did not receive GM-CSF therapy. GM-CSF is an experimental drug...
Immunex fuses GM-CSF and IL-3 in hybrid molecule; studies demonstrate potential...
Press release article from: PR Newswire August 29, 1990 700+ words
IMMUNEX FUSES GM-CSF AND IL-3 IN HYBRID MOLECULE; STUDIES...macrophage colony stimulating factor (GM-CSF) and Interleukin-3 (IL-3). In...times more active than combinations of GM-CSF and IL-3 in its ability to promote bone...
Immunex's GM-CSF advances in clinical trials; significant cancer, possible AIDS...
Press release article from: PR Newswire July 6, 1987 700+ words
IMMUNEX'S GM-CSF ADVANCES IN CLINICAL TRIALS; SIGNIFICANT...certain cancers. Immunex Corporation's GM-CSF (granulocyte-macrophage colony stimulating...three products in human clinical trials, GM-CSF is being tested with cancer and AIDS patients...
GM-CSF bound to membrane increases efficacy of vaccine against...
Newspaper article from: Cancer Weekly December 24, 2002 700+ words
...vaccines containing cells that secreted GM-CSF. "The intent was to enhance antigen...tumor cell lines in the vaccine and GM-CSF receptor positive antigen presenting...containing B16F10 cells that secreted GM-CSF or expressed mbGM-CSF (Novel membrane...
BioVex Submits IND for Clinical Trial of OncoVEX(GM-CSF) in Malignant Melanoma.
Press release article from: PR Newswire May 4, 2005 700+ words
...in malignant melanoma of OncoVEX(GM-CSF), its lead product candidate for the treatment of solid tumours. OncoVEX(GM-CSF) is an oncolytic virus that selectively...also induces tumour cells to secrete GM-CSF, a powerful immune stimulator, potentially...
GM-CSF bound to membrane increases efficacy of vaccine against melanoma.
Newspaper article from: Gene Therapy Weekly December 26, 2002 700+ words
...vaccines containing cells that secreted GM-CSF. "The intent was to enhance antigen...tumor cell lines in the vaccine and GM-CSF receptor positive antigen presenting...containing B16F10 cells that secreted GM-CSF or expressed mbGM-CSF (Novel membrane...
GM-CSF mobilization may raise engraftment syndrome risk.
Newspaper article from: Blood Weekly March 6, 2003 700+ words
...macrophage colony-stimulating factor (GM-CSF) treatment may increase the risk of...of engraftment." Post-transplant GM-CSF treatment was associated with a higher...factor treatment with either G-CSF or GM-CSF. The overall ES rate in this cohort...
GM-CSF mobilization may raise engraftment syndrome risk.(granulocyte-macrophage...
Newspaper article from: Cancer Weekly March 4, 2003 700+ words
...macrophage colony-stimulating factor (GM-CSF) treatment may increase the risk of...of engraftment." Post-transplant GM-CSF treatment was associated with a higher...factor treatment with either G-CSF or GM-CSF. The overall ES rate in this cohort...
For more facts and information, see all results

Source: HighBeam Research, Low Doses Of GM-CSF Not Enough To Stimulate Neutralizing...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA